Avidity Biosciences
RNA
#1831
Rank
โ‚น976.10 B
Marketcap
โ‚น6,478
Share price
0.28%
Change (1 day)
141.03%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: โ‚น976.10 Billion

As of December 2025 Avidity Biosciences has a market cap of โ‚น976.10 Billion. This makes Avidity Biosciences the world's 1831th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น976.10 B216.73%
2024โ‚น308.17 B416.63%
2023โ‚น59.65 B-51.12%
2022โ‚น122.04 B47.09%
2021โ‚น82.97 B18.47%
2020โ‚น70.03 B

End of Day market cap according to different sources

On Dec 21st, 2025 the market cap of Avidity Biosciences was reported to be:

โ‚น976.10 Billion
by Nasdaq info icon info icon
โ‚น976.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
โ‚น564.91 B-42.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น73.52 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น197.43 B-79.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น261.30 B-73.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น10.84 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
โ‚น978.94 B 0.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น12.825 T 1,213.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.814 T 803.07%๐Ÿ‡ฌ๐Ÿ‡ง UK